Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Article in English | MEDLINE | ID: mdl-31492430

ABSTRACT

BACKGROUND: Non-resolving inflammation associates with obesity and insulin resistance, and may be dependent on the balance of inflammatory substances and specialised pro-resolving mediators of inflammation (SPM) that act to halt the inflammatory response. This controlled trial examined the effect of weight loss on neutrophil synthesis of SPM in volunteers with the metabolic syndrome (MetS). METHODS: Volunteers with MetS (n = 42) were matched for age and gender and randomly assigned to a 12-wk weight loss program followed by 4-wk weight stabilization or a 16-wk weight maintenance program. At baseline and 16 weeks, isolated neutrophils were stimulated with calcium ionophore and the released SPM were measured by LC-MS/MS. RESULTS: At baseline the SPM resolvin (Rv) E1, 18R-RvE3, RvD2 and Maresin-1 (MaR-1) were detected from stimulated neutrophils. The concentration of released RvE1 was at least 6-fold that of other detected SPM. Weight loss of 4.7 ±â€¯0.8 kg, led to a 2-fold increase in RvE1, P = 0.013, relative to the weight maintenance group. The increase in RvE1 after weight loss was related to, but independent of leukotriene B4. CONCLUSION: Following weight loss, human neutrophils from individuals with the metabolic syndrome are capable of releasing larger amounts of RvE1 upon stimulation.


Subject(s)
Calcium Ionophores/pharmacology , Docosahexaenoic Acids/analysis , Metabolic Syndrome/therapy , Neutrophils/metabolism , Weight Reduction Programs/methods , Adult , Aged , Chromatography, Liquid , Eicosapentaenoic Acid/analogs & derivatives , Eicosapentaenoic Acid/analysis , Fatty Acids, Unsaturated/analysis , Female , Humans , Male , Metabolic Syndrome/metabolism , Middle Aged , Neutrophils/drug effects , Tandem Mass Spectrometry , Young Adult
2.
BJOG ; 125(13): 1717-1724, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29953717

ABSTRACT

OBJECTIVE: Hysterectomy is the second most common surgery performed mainly for benign uterine pathologies in females. The association between hysterectomy and the subsequent risk of hypertension remains controversial. This study investigated the risk of developing hypertension in women who had a hysterectomy. DESIGN: Population-based retrospective cohort study. SETTING: We used the Taiwan National Health Insurance Research Database with claims data of 1 million randomly selected insured individuals. POPULATION: Women with and without hysterectomy and bilateral salpingo-oophorectomy, aged 30-49 years, were identified in 2000-2013 from the insurance data. METHODS: From the claims data, we identified 6674 women with hysterectomy without hypertension at the time of the surgery. The comparison cohort were 26 696 women randomly selected from women without hysterectomy and hypertension, matched by age and the year hysterectomy was performed. Adjusted hazard ratio (aHR) of hypertension was estimated after controlling for comorbidities. MAIN OUTCOME MEASURE: Prediction for hypertension following hysterectomy for benign disease. RESULTS: Both cohorts had a median age of 43.9 years. After a median follow up of 6.4 years, the incident hypertension was higher in the hysterectomy cohort than in the comparison cohort, with an adjusted hazard ratio (aHR) of 1.35 [95% confidence interval (CI) 1.27-1.44]. The incidence increased with age, with a higher aHR in hysterectomised women aged 40-49 years (aHR 1.37, 95% CI 1.06-1.83) than in those aged 30-39 years (aHR 1.22, 95% CI 1.02-1.46). CONCLUSION: Findings in this study suggest that women with hysterectomy are more likely to be diagnosed with hypertension in the follow-up period. TWEETABLE ABSTRACT: Women with hysterectomy before 50 years of age are at an increased risk of developing subsequent hypertension. PLAIN LANGUAGE SUMMARY: Hysterectomy is one of the most common surgeries for women with benign uterine disease. Hysterectomy may lead to a sudden decline in the production of sex hormone (estrogen and progesterone), which is responsible for vessel wall endothelial dysfunction leading to hardening of arteries and subsequent hypertension. However, the association between hysterectomy and risk of hypertension remains controversial. This study investigated whether premenopausal women have an elevated risk of hypertension after hysterectomy. This study employed the Taiwan National Health Insurance Research Database to identify 6674 women 30-49 years old who had a hysterectomy between 2000 and 2013, and a comparison group of 26 696 women who did not have a hysterectomy matched by age. Women in both the groups had no hypertension at baseline (recruiting date or within 1 year after recruiting date). By the end of 2013, we found that 1196 (17.9%) and 3613 (13.5%) women had developed hypertension in the hysterectomy and the comparison groups, respectively. The hypertension incidence was 1.4-fold greater in the hysterectomy group than in the control group (27.8 versus 20.2/1000 person-years).


Subject(s)
Hypertension/epidemiology , Hysterectomy/statistics & numerical data , Adult , Age Factors , Case-Control Studies , Female , Humans , Incidence , Middle Aged , Retrospective Studies , Risk Factors , Taiwan/epidemiology
3.
QJM ; 111(9): 605-611, 2018 Sep 01.
Article in English | MEDLINE | ID: mdl-29878253

ABSTRACT

BACKGROUND: Multiple sclerosis (MS) is the most common inflammatory demyelinating disease of the central nervous system. Few studies focused on the relationship between septicemia and MS. AIM: To evaluate the potential impact of septicemia on risk for MS. DESIGN: Two cohorts of patients with septicemia and without septicemia were followed up for the occurrence of MS. METHODS: Patients of 482 790 with septicemia was enrolled from the National Health Insurance Research Database between 2001 and 2011 as the study group to match the 1 892 820 individuals, as the control group, by age and gender. Incidence of MS in both groups was calculated. Cox proportional-hazards regressions were performed for investigating hazard ratios (HR) for MS between groups. RESULTS: Septicemia patients had a 3.06-fold (95% CI: 2.16-4.32, P < 0.001) greater risk of developing MS than the matched group. In addition, higher severity of septicemia was associated with higher risk of developing MS (moderate: HR = 4.03, 95% CI: 2.53-6.45, P < 0.001; severe: HR = 11.1, 95% CI: 7.01-17.7, P < 0.001). Similar results also occurred in both male and female patients with septicemia (male: HR = 4.06, 95% CI: 2.17-7.58, P < 0.001; female: HR = 2.72, 95% CI: 1.79-4.11, P < 0.001). Patients without counterpart comorbidities had a significantly higher risk of MS than the controlled group (HR = 3.02, 95% CI: 2.10-4.35, P < 0.001). CONCLUSION: The results indicated septicemia is linked to an increased risk for MS. Aggressively preventing and treating septicemia may be warranted for one of precautionary strategies of MS.


Subject(s)
Multiple Sclerosis/epidemiology , Sepsis/epidemiology , Adolescent , Adult , Age Distribution , Aged , Comorbidity , Databases, Factual , Female , Humans , Incidence , Kaplan-Meier Estimate , Male , Middle Aged , Proportional Hazards Models , Retrospective Studies , Risk Factors , Sex Distribution , Taiwan/epidemiology , Young Adult
4.
Eur J Clin Microbiol Infect Dis ; 33(10): 1809-15, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24838650

ABSTRACT

The association between herpes zoster (HZ) infection and subsequent risk of end stage renal disease (ESRD) in chronic kidney disease (CKD) patients is unknown. We aim to conduct a population-based cohort study to investigate the risks of developing ESRD after a HZ attack in CKD patients. From the Taiwan National Health Insurance Research Database, we identified 1,144 CKD patients who had HZ over the period 1997-2008 as HZ cohort. We selected 3,855 age- and sex-matched CKD patients without HZ as comparison cohort. All subjects were followed until the end of 2008 or censored. Cox-proportional hazard regression model was used to estimate the effects of HZ on ESRD risks. A total of 396 patients developed ESRD during the follow-up period, of which 108 subjects were from the HZ cohort and 288 from the comparison cohort. The log-rank test demonstrated that the HZ cohort had significantly higher risk of developing ESRD than the comparison cohort (P = 0.0071). The adjusted hazard ratio of subsequent ESRD in the HZ cohort was 1.36 (95 % CI 1.09-1.70) and the hazard ratio increased to 8.71 (95 % CI 5.23-14.5) if the HZ cohort was with concomitant diabetes and hypertension. CKD patients with HZ are at an increased risk of subsequent ESRD. CKD patients with HZ, diabetes, and hypertension have extremely high risk of developing ESRD.


Subject(s)
Herpes Zoster/complications , Kidney Failure, Chronic/epidemiology , Renal Insufficiency, Chronic/complications , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Male , Middle Aged , Risk Assessment , Taiwan/epidemiology
5.
Am J Physiol Heart Circ Physiol ; 300(4): H1194-200, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21239640

ABSTRACT

The cytochrome P-450 arachidonic acid metabolite 20-HETE is central to the regulation of vascular tone, renal function, and blood pressure and is synthesized in the rat kidney in response to angiotensin II (ANG II) and endothelin-1 (ET-1). There are very few studies examining the cellular synthesis of 20-HETE in humans. We aimed to measure human neutrophil and platelet 20-HETE levels under basal conditions and after ANG II, ET-1, and calcium ionophore (CaI). 20-HETE was measured in human platelets and neutrophils after saline (control), CaI (2.5 µg/ml), and ANG II or ET-1 (10 nmol/l-1 µmol/l) incubations. The effect of cells, which were preincubated with the ω-hydroxylase inhibitor N-hydroxy-N'-(4-butyl-2-methylphenyl) (HET0016, 10 nM), ANG II types 1 or 2 (AT(1) or AT(2)) receptor inhibition with irbesartan (1 µmol/l) or PD-123319 (1 µmol/l), or endothelin receptor subtypes A or B (ET(A) or ET(B)) receptor inhibition with BQ-123 or BQ-778 (100 nmol/l), was studied. Neutrophil and platelet content and release of 20-HETE was significantly increased by CaI and blocked by the ω-hydroxylase inhibitor HET0016. ANG II and ET-1 significantly increased neutrophil and platelet content and release of 20-HETE. ANG II increased 20-HETE via the AT(2) receptor. ET-1 increased 20-HETE through the ET(B) receptor in platelets and both the ET(A) and ET(B) receptors in neutrophils. These studies show that human platelets and neutrophils synthesize 20-HETE in response to ANG II and ET-1. 20-HETE synthesis in both cell types was predominantly mediated via the AT(2) and ET(B) receptors. Stimulation via these receptor pathways has generally been thought to be cardioprotective and requires further studies in clinical situations associated with low-grade inflammation or where ANG II and ET-1 are elevated to clarify the role of 20-HETE.


Subject(s)
Angiotensin II/pharmacology , Blood Platelets/drug effects , Endothelin-1/pharmacology , Hydroxyeicosatetraenoic Acids/biosynthesis , Neutrophils/drug effects , Adult , Aged , Amidines/pharmacology , Angiotensin Receptor Antagonists/pharmacology , Biphenyl Compounds/pharmacology , Blood Platelets/metabolism , Calcium Channels/drug effects , Cells, Cultured , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Enzyme System , Humans , Imidazoles/pharmacology , Ionophores/pharmacology , Irbesartan , Male , Middle Aged , Neutrophils/metabolism , Oligopeptides/pharmacology , Peptides, Cyclic/pharmacology , Piperidines/pharmacology , Pyridines/pharmacology , Tetrazoles/pharmacology , Young Adult
6.
J Clin Endocrinol Metab ; 92(12): 4747-52, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17925339

ABSTRACT

CONTEXT: Neutrophil (polymorphonuclear neutrophil) production of leukotriene B4 (LTB4) may be associated with alterations in immune and inflammatory function that characterize the metabolic syndrome (MetS). OBJECTIVE: We investigated whether polymorphonuclear neutrophil production of LTB(4) and its metabolites 20-hydroxy-LTB4 (20-OH-LTB4) and 20-carboxyl-LTB4 were altered in subjects with features of the MetS before and after weight reduction. DESIGN, SETTING, PATIENTS, AND INTERVENTION: In a case-controlled comparison, men and postmenopausal women with features of the MetS were matched with controls. Subjects with MetS were then matched and randomly assigned to either a 12-wk weight reduction study followed by 4-wk weight stabilization or 16-wk weight maintenance. MAIN OUTCOME MEASURES: Measurements were performed at baseline and at the end of the 16-wk period. Stimulated neutrophil LTB4 and its metabolites were measured by HPLC. RESULTS: In the case-controlled study, body mass index, waist circumference, blood pressure, fasting triglycerides, and glucose were all significantly increased in subjects with features of the MetS (P < 0.05). Production of LTB4 and 20-OH-LTB4 was significantly lower compared with controls (P < 0.005). The weight loss intervention resulted in a 4.6-kg reduction in body weight and 6.6-cm decrease in waist circumference relative to controls and a significant increase in LTB4 and 20-OH-LTB4. CONCLUSIONS: Subjects with features of the MetS have lower stimulated LTB4, which is not due to increased metabolism of LTB4. Weight reduction restored the production of neutrophil LTB4, suggesting that in addition to modifying cardiovascular risk, weight loss may also help with the management of perturbed inflammatory responses in overweight subjects.


Subject(s)
Leukotriene B4/biosynthesis , Metabolic Syndrome/metabolism , Weight Loss/physiology , Adult , Aged , Blood Glucose/metabolism , Body Mass Index , C-Reactive Protein/metabolism , Case-Control Studies , Energy Intake , Female , Humans , Immunoenzyme Techniques , Insulin/blood , Lipoproteins, HDL/blood , Lipoproteins, LDL/blood , Male , Middle Aged , Neutrophils/metabolism , Triglycerides/blood
8.
Vaccine ; 19(4-5): 437-41, 2000 Oct 15.
Article in English | MEDLINE | ID: mdl-11027806

ABSTRACT

The combination of hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccinations can offer convenience, increased compliance and cost saving. We have studied the immunogenicity, reactogenicity and safety of combined hepatitis A and B vaccination in young adults (16-35 years old). Eighty healthy young adults were divided into two random groups. One group received the combined hepatitis A and B vaccine (HAB) in one arm while the other group was administered concomitant hepatitis A and B vaccines (HAV + HBV) in the right and left arms, respectively. The immunogenicity, reactogenicity and safety were assessed after each dose in both the groups. In local symptoms, the percentage of the combined HAB group was lower than the HAV + HBV group, and the general symptoms were noted in approximately 30% of each group without any significant difference. No serious adverse effects were noted. All the subjects were seropositive for antibody to hepatitis A virus (anti-HAV) after one dose of vaccine, and remained seropositive after three doses in both groups. The seropositive rate for antibody to hepatitis B surface antigen (anti-HBs) was significantly higher (84%) in the combined HAB group than the concomitant HAV + HBV group (62%), (p<0.05) after dose two, and all the subjects were seropositive (100%) after the third dose. The GMTs of anti-HAV and anti-HBs were not significantly different between groups 1 and 2 (p>0.1) except in month 6 when the GMT of anti-HBs was higher in HAB group (p=0.0039). The combined HAB vaccine was found to be safe, well tolerated and had less local symptoms in young adults. The immunogenicity and reactogenicity were similar to the concomitant HAV + HBV vaccines.


Subject(s)
Hepatitis A Vaccines/administration & dosage , Hepatitis B Vaccines/administration & dosage , Adult , Female , Hepatitis A/prevention & control , Hepatitis A Antibodies , Hepatitis A Vaccines/adverse effects , Hepatitis A Vaccines/immunology , Hepatitis Antibodies/blood , Hepatitis B/prevention & control , Hepatitis B Antibodies/blood , Hepatitis B Vaccines/adverse effects , Hepatitis B Vaccines/immunology , Humans , Male , Safety , Vaccines, Combined/administration & dosage , Vaccines, Combined/adverse effects , Vaccines, Combined/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/adverse effects , Vaccines, Synthetic/immunology
9.
Article in Chinese | MEDLINE | ID: mdl-1296436

ABSTRACT

A Diabetes camp provides children with fun and educational experience. Seventeen diabetic school children (12 boys and 5 girls) participated in a short-term diabetes camp from April 16 to 17, 1988. Their ages ranged from 8.5 to 13.2 years with an average of 11.3 +/- 1.5 (mean +/- SD) years. The duration of their diabetes varied from 0.05 to 5.3 years with an average of 2.7 +/- 3.3 years. The camp staff consisted of a pediatric endocrinologist, 3 nurses, 4 dietitians, 3 social workers, 4 assistant diabetes educators, and 2 counsellors who were specialized in music and recreational activities. The children's abilities in managing their diabetes were assessed by using a scoring system before and after the camping. Wilcoxon matched-pairs signed-rank tests with significance levels set at p < 0.05 (two-tailed) were conducted to determine whether there were any significant changes in the results from pre- and postcamp assessments. The children showed significant improvement in using glucose-monitoring devices, drawing insulin, injecting insulin, and choosing the right exchange of food with the p values of less than 0.05, 0.01, 0.01, and 0.01 respectively. We concluded that this short-term diabetes camp was educational for school children with diabetes. The campers improved their knowledge and skill in management of diabetes.


Subject(s)
Diabetes Mellitus, Type 1/therapy , Patient Education as Topic , Adolescent , Camping , Child , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...